pharma
Grab a front-row seat at today’s hottest conferences with Hedge Fund Alpha! We provide coverage of all the best stock-picking events, including the Sohn conferences, Invest for Kids, the Ben Graham Conference, Global Alts New York, Forbes Iconoclast, and the London Value Investor Conference. We also cover the annual Morningstar Investment Conference. Hedge Fund Alpha brings you the latest news and stock picks from these and other conferences around the world. Find out what the world’s top investors are thinking and read about the stocks that are top of mind for them. Hedge Fund Alpha is your go-to source for all the top conferences from around the globe. Access in-depth editorial analysis of conference and original PDFs. Reading for new ideas, personal notes, and applying insights to your portfolio or research is encouraged. Scraping, bulk downloading, internal redistribution, or using data to create a competing service or database is not permitted. For enterprise data licensing, we provide conference history as 2011, normalized entities, timestamps, novelty data, and customizations. This data is useful for signals research and can be used by quant funds, fintech providers, market makers, and other firms. Contact [email protected] (Subject: "Conference Database Licensing") for inquiries.
Top Conferences
Sohn Hong Kong
2025 Sohn Hong Kong: Vatsal Mody On India’s Value Pharmacy Leveraging Vertical Integration
Invest for Kids: Bull Thesis for Verona Pharma
London Quality-Growth Investor Conference: Royalty Pharma’s Growth Opportunity
Pfizer To Acquire Arena Pharmaceuticals
PharmaCielo: 100% Downside on Co-Founder’s History of Securities Fraud Allegations: Hindenburg Research
Value Briefs
Recro Pharma: A Hidden Gem with 55% Upside
Purdue Pharma Announces Agreement In Principle On Landmark Opioid Litigation Settlement
Buffett On Pharma Investing, Raising Capital and Finding Mispriced Securities
Here’s Why Drug-Distribution And Pharmacy Stocks Are Bargains Now
4d Pharma PLC (DDDD) – Bad News But Strange Director Buying
This Healthcare Fund Rode High On Enanta Pharmaceuticals In Q1
Value Briefs
GE To Sell BioPharma Business To Danaher For $21.4 Billion
Visualizing The Future Of The Pharma Market
Citron Claims “Smoking Gun” On Ligand Pharmaceuticals
Value Briefs
Bristol-Myers Squibb To Acquire Celgene To Create A Premier Innovative Biopharma Company
Needle in a Haystack Is for Pharmaceuticals Investors
Filing Season Finds: Tuesday, March 6 – Specialty pharmacy red flag
Big Pharma Tax Breaks Will Drive Wave Of M&A

